Detailed information for compound 515996

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 280.281 | Formula: C15H12N4O2
  • H donors: 0 H acceptors: 3 LogP: 2.54 Rotable bonds: 3
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCOc1nc2ccccc2n2c1nc(n2)c1ccco1
  • InChi: 1S/C15H12N4O2/c1-2-20-15-14-17-13(12-8-5-9-21-12)18-19(14)11-7-4-3-6-10(11)16-15/h3-9H,2H2,1H3
  • InChiKey: HYYBJWPPFMULNP-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens adenosine A1 receptor Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Brugia malayi hypothetical protein adenosine A1 receptor 326 aa 305 aa 21.0 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Echinococcus granulosus netrin receptor unc 5 0.0015 0.1029 0.1029
Brugia malayi Immunoglobulin I-set domain containing protein 0.0015 0.1029 0.2393
Entamoeba histolytica hypothetical protein 0.0038 0.4299 0.5
Schistosoma mansoni netrin receptor unc5 0.0015 0.1029 0.2393
Echinococcus granulosus death domain containing protein 0.0015 0.1029 0.1029
Echinococcus granulosus ankyrin repeat and death domain containing protein 0.0015 0.1029 0.1029
Brugia malayi Protein kinase domain containing protein 0.0015 0.1029 0.2393
Echinococcus multilocularis netrin receptor unc 5 0.0015 0.1029 0.1029
Echinococcus granulosus Basic leucine zipper bZIP transcription 0.0038 0.4299 0.4299
Schistosoma mansoni retinoblastoma-binding protein 4 (rbbp4) 0.0015 0.1047 0.2437
Brugia malayi Uncoordinated protein 44 0.0015 0.1029 0.2393
Loa Loa (eye worm) hypothetical protein 0.0015 0.1047 1
Schistosoma mansoni ankyrin 23/unc44 0.0015 0.1029 0.2393
Echinococcus multilocularis Basic leucine zipper (bZIP) transcription 0.0038 0.4299 0.4299
Entamoeba histolytica hypothetical protein 0.0038 0.4299 0.5
Onchocerca volvulus Netrin receptor homolog 0.0015 0.1029 1
Entamoeba histolytica hypothetical protein 0.0038 0.4299 0.5
Echinococcus multilocularis Ankyrin 0.0015 0.1047 0.1047
Brugia malayi hypothetical protein 0.0038 0.4299 1
Echinococcus multilocularis ankyrin repeat and death domain containing protein 0.0015 0.1029 0.1029
Loa Loa (eye worm) immunoglobulin I-set domain-containing protein 0.0015 0.1029 0.9823
Loa Loa (eye worm) hypothetical protein 0.0015 0.1029 0.9823
Schistosoma mansoni hypothetical protein 0.0015 0.1029 0.2393
Schistosoma mansoni hypothetical protein 0.0038 0.4299 1
Brugia malayi Death domain containing protein 0.0015 0.1029 0.2393
Schistosoma mansoni transcription factor LCR-F1 0.0038 0.4299 1
Entamoeba histolytica hypothetical protein 0.0038 0.4299 0.5
Echinococcus multilocularis nuclear factor of activated T cells 5 0.0077 1 1
Echinococcus granulosus Ankyrin 0.0015 0.1047 0.1047

Activities

Activity type Activity value Assay description Source Reference
Inhibition (binding) = 34 % Displacement of [3]DPCPX from human adenosine A2B receptor expressed in HEK293 cells at 1 uM ChEMBL. 18249548
Inhibition (binding) = 34 % Displacement of [3]DPCPX from human adenosine A2B receptor expressed in HEK293 cells at 1 uM ChEMBL. 18249548
Inhibition (binding) = 38 % Displacement of [3]ZM241385 from human adenosine A2A receptor expressed in HeLa cells at 1 uM ChEMBL. 18249548
Inhibition (binding) = 38 % Displacement of [3]ZM241385 from human adenosine A2A receptor expressed in HeLa cells at 1 uM ChEMBL. 18249548
Inhibition (binding) = 69 % Displacement of [3]NECA from human adenosine A3 receptor expressed in HeLa cells at 1 uM ChEMBL. 18249548
Inhibition (binding) = 69 % Displacement of [3]NECA from human adenosine A3 receptor expressed in HeLa cells at 1 uM ChEMBL. 18249548
Ki (binding) = -5.43 Displacement of [3]DPCPX from human adenosine A1 receptor expressed in CHO cells ChEMBL. 18249548
Log Ki (binding) = 5.43 Displacement of [3]DPCPX from human adenosine A1 receptor expressed in CHO cells ChEMBL. 18249548

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.